Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

69 results about "Intracellular calcium ion" patented technology

Modified ghrelin polypeptides

InactiveUS7385026B1Increasing intracellular calcium ion concentrationIncrease calcium ion concentrationFungiBacteriaSomatotropin secretionIntracellular calcium ion
The present invention provides a peptide-type compound which induces secretion of growth hormone and which has the activity of increasing the intracellular calcium ion concentration, wherein at least one amino acid is replaced by a modified amino acid and / or a non-amino acid compound, or a pharmaceutically acceptable salt thereof.
Owner:KANGAWA KENJI

American ginseng milk and its confection method

The American ginseng milk is compounded with American ginseng, milk, thickener, stabilizer, butter and sugar and through mixing. The present invention has the positive effects of restoring brain from fatigue, delaying senility of brain, regulating fat metabolism, lowering cholesterol, preventing the motor fatigue and damage caused by free radical induction, regulating absorption and blocking of calcium ion on cell membrane and avoiding the negative effect of accumulation of calcium ion inside cell.
Owner:陆军 +1

Microfluidic chip group used for screening formyl peptide receptor agonist and screening method

InactiveCN101782569AAvoid influenceReal-time monitoring of the transient flow of calcium ionsChemiluminescene/bioluminescenceScreening methodAgonist
The invention provides a microfluidic chip group used for screening a formyl peptide receptor agonist and a screening method. The microfluidic chip group consists of three microfluidic chip units, i.e. a cell chemotaxis detection unit, a receptor endocytosis detection unit and a calcium ion transient flow process monitoring unit. The invention designs a group of chips by aiming to the characteristics of different cell function analytical experiments, can respectively carry out cell chemotaxis, receptor endocytosis detection and calcium ion transient flow (release) process monitoring, and judges biologic activity thereof by comprehensively evaluating influence on the formyl peptide receptor signal conduction path by an alternative compound. Compared with the traditional technology, the invention realizes real-time monitoring of the intracellular calcium ion releasing process and saves a series of complex operations, such as film laying, film obtaining, cell doctoring, fixing, dying andthe like, thereby greatly saving the analysis time and lowering the detection cost.
Owner:DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI

Calcineurin activators

A calcineurin activator, comprising the following protein (a) or (b) as an active ingredient and having the action of increasing intracellular calcium ion concentration through the influx of calcium ions into eukaryotic cells: (a) a killer protein (KLKP), being composed of 3 subunits consisting of amino acid sequences represented by SEQ ID NOS: 2, 3, and 4, respectively, and being produced by Kluyveromyces lactis killer yeast; or (b) a protein, being the same as protein (a) except for differing from protein (a) in that at least one of the 3 subunits consists of an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2, 3, or 4 by deletion, substitution, or addition of 1 or several amino acids, and having Kluyveromyces lactis killer protein (KLKP) activity.
Owner:NAT INST OF AGROBIOLOGICAL SCI

Pharmaceutical uses of NBC1 N-cyano amide sulfide inhibitor S0859

The present invention relates to pharmaceutical uses of a Na<+>-coupled HCO3< > transporter (NBC1) N-cyano amide sulfide inhibitor S0859, and provides uses of a Na<+>-coupled HCO3< > transporter (NBC1) N-cyano amide sulfide inhibitor S0859 in preparation of heart failure treating drugs. According to the present invention, the results prove that the inhibitor S0859 can regulate the intracellular calcium ion homeostasis after myocardial infarction, improve ventricular remodeling, and inhibit intracellular calcium overload so as to inhibit ventricular remodeling, such that the invention can provide a new heart failure treating drug so as to effectively delay heart failure and ventricular remodeling caused by myocardial infarction.
Owner:NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV

Application of 1,2,4-triazole heterocyclic compound in preparation of drugs to prevent or treat central system related diseases

The invention relates to the technical field of 1,2,4-triazole heterocyclic compounds and discloses application of a 1,2,4-triazole heterocyclic compound in the preparation of drugs to prevent or treat central system related diseases. The 1,2,4-triazole heterocyclic compound [1,2,4]-triazolo-[1,5-a]pyrimidone heterocyclic compound shown as the general formula (I) or 7-alkoxy-1,2,4-triazolo-[1,5-a]pyrimidine heterocyclic compound shown as the general formula (II). The 1,2,4-triazole heterocyclic compound disclosed herein can well inhibit, on cellular models, intracellular calcium ion oscillations and 4-AP induced epilepsy, and on animal models (mouse), has good anti-epilepsy activity and significant calming effect.
Owner:QINGDAO UNIV OF SCI & TECH

Antibacterial antistatic PS composite material and preparation method thereof

The invention relates to an antibacterial antistatic PS composite material and a preparation method thereof. The antibacterial antistatic PS composite material is prepared from the following components in parts by weight: 80-100 parts of PS, 4-6 parts of an antibacterial agent, 4-8 parts of modified graphene and 0.1-0.5 part of an antioxidant, wherein the antibacterial agent is a praseodymiumPr ion antibacterial agent. Pr ions have the function of antagonizing intracellular calcium ions, and calcium ions are ions maintaining the normal physiological activities of cells, so that the Pr ions caninterfere with the normal life activities of bacterial cells and cause bacterial death. Through the addition of the special antibacterial agent, the antibacterial property of the PS composite material is enhanced; and through the addition of the modified graphene, the improvement on the antistatic property of the PS composite material is facilitated.
Owner:ANHUI JIANGHUAI AUTOMOBILE GRP CORP LTD

Fluorogenic calcium ion indicators and methods of using the same

The present disclosure provides fluorogenic compounds useful for preparing fluorescent calcium ion indicators, the fluorescent indicators themselves, and the use of the fluorescent indicators in methods of detection, discrimination and quantification of metal ions. The subject fluorogenic compounds and fluorescent ion indicators can include a chelating group based on a 2-aminophenoxyethylene glycol 2-aminoethyl ether, N,N,N′,N′-tetraacetic acid (PEGTA) moiety or precursor thereof where the phenyl group of the PEGTA is substituted with or fused with a fluorophore moiety of interest. The subject methods find use in the detection of intracellular calcium ions. Also provided are kits for use in practicing the subject methods.
Owner:AAT BIOQUEST

Cell model and screening method for screening calcium-activated chloride ion channel inhibitor

The invention provides a cell model and a screening method for screening a calcium-activated chloride ion channel inhibitor. The screening method sequentially comprises the steps of (1) constructing eukaryotic expression vectors of Anoctamin1 or Anocatmin2 and YFP-H148Q / I152L; (2) stably transfecting the two vectors into FRT (Fisher rat thyroid) cells respectively to ensure that the RFT cells co-express two proteins of YFP-H148Q / I152l and Anoctamin1 or Anocatmin2, and performing multiple times of limiting dilution to obtain an FRT cell model; (3) transferring the FRT cell model to a black-wall microporous plate with a black wall and a transparent bottom; (4) adding a small molecular compound to be detected into the black-wall microporous plate, incubating, then adding a regent for raising the concentration of calcium ions in cells and high-concentration iodide ions, and screening the calcium-activated chloride channel inhibitor by detecting the change of relative fluorescence intensity.
Owner:JINLIN MEDICAL COLLEGE

Hydroxy fatty acid oligomer and application in regulating calcium ion concentration in cell

The invention provides a hydroxy fatty acid oligomer and an application of the hydroxy fatty acid oligomer in adjusting the growth of cells and improving the concentration of calcium ions in the cells. As proved by experiments, the hydroxy fatty acid oligomer can inhibit the proliferation of cancer cells, induce the apoptosis and the death of the cells, prolong the G1 period of the cells and reduce the segmentation degree of the cancer cells. As shown by the further calcium imaging technical detection, the oligomer also can stimulate the increase of the concentration of dissociative calcium ions in the cells.
Owner:SHANTOU UNIV

Responsive nanoparticles with mitochondrion-targeted function, preparation method therefor and application of responsive nanoparticles

The invention provides a preparation method for responsive nanoparticles with a mitochondrion-targeted function. The method comprises the steps: S1) mixing an inorganic calcium salt, dopamine and an alcohol solvent, so as to obtain a precursor solution; and S2) placing the precursor solution and ammonium bicarbonate in a closed environment in a noncontact manner, and carrying out heating for a reaction, so as to obtain the responsive nanoparticles. Compared with the prior art, the responsive nanoparticles prepared by the method has the advantages that the responsive nanoparticles are uniform in shape and uniform in size, have relatively high thermal stability and chemical stability, can achieve excited response of a variety of light of different wavelengths, can continuously generate calcium ions in tumor cells to increase a concentration of the calcium ions in the cells, and can also cooperate with micromolecular drugs to inhibit a calcium ion discharging action of a mitochondrion andcooperate with the micromolecular drugs to jointly destroy functions of the mitochondrion so as to promote damage of the mitochondrion, and thus, the aim of tumor therapy is achieved, so that the responsive nanoparticles have great potentials in cancer therapy in the future.
Owner:CHANGCHUN INST OF APPLIED CHEMISTRY - CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products